Arcturus Therapeutics is actively engaged in partnering discussions. Our strategic alliances fall into several categories:
- Partnering RNA medicines, including access to LUNAR and UNA Technologies
- Co-Development Opportunities
Please contact bd@arcturusrx.com regarding any business development opportunities.
October 2, 2019
Arcturus Therapeutics to Present at Three Upcoming Investor Conferences
read more
September 26, 2019
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
read more
September 23, 2019
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. and Re-Appointment of Andy Sassine to the Board of Directors
read more
